Synergy CHC Corp. announces financial results for Q3 2025, reporting 11th consecutive quarter of profitability and double-digit revenue growth. Key partnerships with Kroger and Wakefern strengthen retail reach. Completed $4.4 million public offering in August, boosting working capital for growth. Recent business highlights include new distribution wins and the appointment of Costco executive to the Board of Directors.

In Q3 2025, Synergy reported $8.0 million in revenue, up 12.4% from the same period in 2024. Gross margin increased to 70.9%, income from operations rose to $1.28 million, and net income was $125.3 thousand. Earnings per share was $0.01, and adjusted EBITDA per share was $0.15. The company reduced liabilities by $3.3 million in Q3.

Synergy CHC Corp. had approximately $1.0 million in cash and cash equivalents as of September 30, 2025, with a working capital surplus of $16.68 million. Inventory increased to $2.1 million. Cash used in operating activities for the nine months ended September 30, 2025, was $3.21 million. EBITDA and adjusted EBITDA figures for the period were $1.31 million and $1.52 million, respectively.

Synergy will host a conference call on November 13, 2025, to discuss the results. The company develops and markets consumer health and wellness products, with flagship brands FOCUSfactor® and Flat Tummy®. Forward-looking statements regarding brand expansion and growth initiatives were included. Balance sheets and financial statements for Q3 2025 were also provided.

For the nine months ended September 30, 2025, net income was $2.47 million, with comprehensive income totaling $2.49 million. Cash flow from operating activities showed a net decrease of $3.21 million. Financing activities included proceeds from issuing common stock and advances from related parties. Supplemental disclosures of cash flow information and noncash investing and financing activities were also detailed.

Read more at GlobeNewswire: Synergy CHC Corp. Reports Third Quarter 2025 Financial